Gottlieb Confirmation: He's Willing To Disagree With Trump, Price
Senators test US FDA commissioner nominee's willingness to defend agency independence during confirmation hearing and probe potential conflicts of interest.
You may also be interested in...
Devices, or drug-delivery device, alternatives for pain control may provide at least a partial solution to the nation's opioid abuse epidemic, FDA Commissioner-nominee Scott Gottlieb said at his April 5 confirmation hearing before the Senate Health, Education, Labor, and Pensions Committee.
President Trump's initial budget plan for US FDA would, it appears, make industry-paid user fees a much larger proportion of the agency's budget, but details are lacking. As is, the plan could complicate agreements that came out of FDA-industry user-fee negotiations last summer, but observers say this is just the first step in a process and Congress will ultimately decide. Trump would also shave 22% from the National Institutes of Health.
Updated guidance indicates food and drug activities fall within public safety exemption, but interpretation of language remains unclear.